Cite
APA Citation
Rocca, C., Scavello, F., Colombo, B., Gasparri, A. M., Dallatomasina, A., Granieri, M. C., Amelio, D., Pasqua, T., Cerra, M. C., Tota, B., Corti, A., & Angelone, T. (2019). physiological levels of chromogranin A prevent doxorubicin‐induced cardiotoxicity without impairing its anticancer activity. FASEB journal, 33(6), 7734–7747. http://access.bl.uk/ark:/81055/vdc_100102561573.0x000047